Avian Influenza: A Ticking Time Bomb?
"Maybe more than 100 million deaths in a few weeks worldwide."
This worst-case scenario was brought up in one of our medical school microbiology lessons covering viral infections and the dangers of flu (influenza). All the students were suddenly very quiet. The professor's statement also peaked my interest in one of the most important global challenges of the 21st century.
On March 12, 2004, the World Health Organization (WHO) in accord with representatives from different countries and the pharmaceutical industry underlined the urgent need for the development of a vaccine against dangerous variations of the flu virus.
There is a "unique window of opportunity" to avoid a horrific pandemic, explained Dr. Klaus Stöhr, director of the WHO's global influenza program. He said it would be costly, but there are no alternatives.
A cruel lesson ahead for mankind
Since the early days of global air travel, scientists have warned that one day humankind will face a remorseless enemy. They say this enemy will be an aggressive and highly infectious virus, which, due to modern air traffic, will spread all over the world within days.
Some scientists are afraid that mankind will not consider preventative measures as necessary until it is too late.
As we have seen, the Ebola virus frequently kills many in Central Africa, and movies like "Outbreak" (1995) and "Twelve Monkeys" (1996) have infected cinema visitors worldwide. But as usual, it takes more than alarming movies or so-called "Third World" tragedies for governments to open their coffers and fund essential scientific investigations.
Naturally, before the Hong Kong outbreak of 1997, mankind tended to think of global pandemics as being scourges of the past. But the bird flu (avian influenza) pathogen H5N1, which was believed to only affect bird species, ended up infecting 16 people and killed four. Since this occurred next to an international airport, concerns were raised whether H5N1 could be the beginning of a deadly global pandemic.
With every year that passed, the virus continued to spread over East Asia. It forced national governments in China, Vietnam, Thailand, Indonesia, Japan and South Korea to kill millions of potentially infected poultry. The virus killed about 70 persons worldwide and at least 13 already in 2005.
But how can a virus that kills less than 100 people over a period of four years incite governments, the pharmaceutical industry and the food industry to institute the necessary, expensive measures and intensified research?
The answer is that back in September 2004 in Thailand, H5N1 has already been transmitted from human to human. Such vectors cannot be ruled out anymore and the virus may someday become a primarily human affliction.
The danger: An H5N1/H3N2-mutant
Around 16,000 people annually die of the common flu in Germany. One of the most important of these human-afflicting subtypes of the influenza virus is the pathogen type H3N2. Many of these deaths, often referred to as pneumonia, could be avoided.
A Swedish study conducted from 1996 to 1999, including 100,242 people over 65, demonstrated that annual vaccinations were able to reduce influenza-related hospital treatment by 46 percent and serious cases of influenza by 29 percent. The numbers of deaths were reduced by 57 percent.
When the power of the human immune system weakens from the age of 35 onward, the risk of infections rises. So those most at risk are unvaccinated people over the age of 65 and those with a weak immune system like HIV patients, people undergoing chemotherapy or who have an otherwise compromised immune system and children.
In contrast to the common flu, the bird flu seems to have the potential to more readily afflict people with a normal immune system. Moreover, H5N1 more often leads to death than H3N2.
There remains no vaccination for bird flu. Flu vaccines are produced when eggs are infected with the common flu viruses. The procedure takes four months on average. This fact alone demonstrated that current health care systems are unable to adequately react to a possible outbreak.
The major problem, however, is that the virus does not only kill birds (and humans), but also destroys the eggs of hens needed for industrial vaccine production.
If H5N1 ever succeeds in combining with H3N2 -- and if this hybrid does not lose its deadly effect -- the then "former bird flu" will spread like the common flu. This kind of nightmare hybrid may appear when a person is simultaneously infected with both virus types. Such a scenario underlines the necessity of vaccinating older people against the common flu, in the interest of the individual and the general population.
There is another possibility for hybrid creation, too: pigs. Both the bird flu virus, H5N1, and the common flu virus, H3N2, manage to survive in pigs. Naturally, within the pig's body an H5N1/H3N2-mutant can be formed.
The American Centers for Disease Control (CDC) high-security labs in the city of Atlanta are trying to artificially combine both types. The scientists' intention is to determine whether a hybrid form can be created and if it will harbor its deadly attributes.
Strategies to avoid the worst-case scenario
In order to avoid a scenario that eclipses the Spanish Flu Pandemic of 1918, important steps have to be taken by national governments and individuals.
One is to end mass animal-husbandry. Too many individuals are kept in too little space, exposing them to massive social stress in which diseases find a perfect environment to develop. The same argument is valid for slums and refugee camps. Ending poverty helps contain infectious diseases.
Furthermore, pigs and poultry must be kept separate on these massive agricultural plots.
Another important step is to inoculate the population, especially older citizens, with the (completely safe) flu vaccines, not only to rule out recombination of H5N1 and H3N2 genes in the human body, but to effectively determine whether a person suffers from the common flu or the bird flu.
In addition, new strategies to create vaccines that can be produced within a few days, independent from the eggs of hens, must be investigated. Several pharmaceutical companies are actually working to find new ways to produce such flu vaccines.
Maybe the most important measurement is to check every passenger before he or she departs on an international flight. We should not just worry about people carrying knives onboard, but ensure that he or she is not ill. If a global pandemic starts, like during the days of SARS, international air traffic must be reduced to a bare minimum.
Last, but not least, new medications have to be developed to treat persons suffering from the flu. At the moment there are only so-called "neuraminidase inhibitors" to which virus types can rapidly adapt
http://english.ohmynews.com/articleview/ar...1&isPrint=print